Cookies & Privacy

We use essential cookies to make our site work. With your permission, we’ll also use analytics and marketing cookies to improve your experience. You can change your choice anytime.

See our Privacy Policy for details.

Manage preferences
Cookie preferences
Back to Industry News
Medtech

Bloomberg: Goldman Sachs Leads $3.75B Debt Deal for DuPont Unit

Summary generated with AI, editor-reviewed
Heartspace News Desk
Source: Bloomberg.com

Key takeaways

  • Goldman Sachs Group Inc
  • 75 billion debt financing package to support Arclin Inc
  • 's acquisition of DuPont de Nemours Inc
Goldman Sachs Group Inc. is spearheading a $3.75 billion debt financing package to support Arclin Inc.'s acquisition of DuPont de Nemours Inc.'s Aramids business, according to a Bloomberg report. The financing, comprised of a $3 billion term loan, a $250 million delayed-draw term loan, and a $500 million revolving credit facility, is currently being marketed to investors by Goldman Sachs. Sources familiar with the private transaction provided the details.

Related Topics

Goldman SachsDuPontArclindebt financingacquisition

Share Your Thoughts

(0 comments)

Be the first to share your thoughts on this article!

Stay Updated

Create alertsRead original